Nuvation Bio Inc.
USD4.72
-0.18 (-3.67%)
CEO
David T. Hung
IPO Date
2020-08-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Country
US
Open
$4.85
Prev. Close
$4.90
Day Low
$4.59
Day High
$4.85
52W Low
$1.57
52W High
$9.75
Market Cap
$1.64B
Volume
3.22M
| 123,397 |
| $4.79 |
| 26 May 2026 | FALBERG KATHRYN E | director | A-Award | Acquired | 123,397 | $4.79 |
| 26 May 2026 | BLICKENSTAFF KIM D | director | A-Award | Acquired | 123,397 | $4.79 |
| 26 May 2026 | Bazemore Robert B | director | A-Award | Acquired | 123,397 | $4.79 |
| 26 May 2026 | Cui Xiangmin | director | A-Award | Acquired | 123,397 | $4.79 |
| 26 May 2026 | Cui Xiangmin | director | A-Award | Acquired | 76,923 | $5.91 |
| 21 Apr 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | M-Exempt | Acquired | 36,750 | $2.93 |
| 21 Apr 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | S-Sale | Disposed | 36,750 | $5.01 |
| 21 Apr 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | M-Exempt | Disposed | 36,750 | $2.93 |